Our website is made possible by displaying non-intrusive online advertisements to our visitors.
Please consider supporting us by disabling or pausing your ad blocker.
该发现公布在“2025国际阿尔兹海默症和帕金森氏病会议（AD/PD 2025）”上，该会议于上周六在维也纳落幕。会上，卓睿（TauRx）首席执行官兼联合创始人克劳德·维希克教授（Prof Claude Wischik）展示了HMTM近三期临床试验的结果，并与来自“阿尔茨海默病关键路径（CPAD）研究所”数据库中严格匹配的安慰剂组数据进行了对比。该数据库涵盖全球36项试验近10,000名患者的信息。
MHRA response to HMTM Marketing Authorisation Application
TauRx Therapeutics Management Ltd can confirm it has received formal confirmation from the UK Medicines and Healthcare products Regulatory Agency (MHRA) that it requires some further information before a final determination on the suitability of hydromethylthionine mesylate (HMTM), as a potential oral treatment for Alzheimer’s disease, can be reached.
TauRx colleagues are in the process of working through the request in order to ensure answers are collated as expediently as is practicable.
The company is committed to working with the MHRA and other organisations as required, and further updates will be provided in due course.
如果在收购期间，老板在市场买入更高的股价，就一律调高收购价
4.10 Purchases in the open market
If the Offeror or any of the PACs purchase or agree to purchase any of the Offer Shares during the offer period at a consideration that is higher than the Offer Price, the Offeror will increase the Offer Price ...